Read Announcement View Product Photos Summary Company Announcement Date: FDA Publish Date: Product Type: Drugs Reason for Announcement: Recall Reason DescriptionProducts are out of specification Company Name: Olympia Pharmacy Brand Name: Brand Name(s)Olympia Pharmaceuticals Product Description: Product DescriptionCompounded Injectables Company Announcement Olympia Pharmacy is voluntarily recalling 11 specific lots of Trimix Formulas F-9, T-105, SB-4, Sermorelin, Sincalide, Hydroxocobalamin, and NAD, compounded injectables to the consumer level
the cognitive-research literature commonly reports total daily intranasal amounts in the milligram range divided across multiple administrations
Declination of mental health Women with a B12 deficiency may find it harder to manage stress and may feel overwhelmed, which can have a compounding effect on their physical health and overall well-being
Vukojevic, V., Sikiric, P., Seiwerth, S., Petrovic, I., Marovic, A., Drmic, D., & Staresinic, M
Key factors that influence pricing include peptide purity percentage (98% to 99%), manufacturing origin (research-grade vs GMP-certified), delivery form (injectable vs capsule), and testing transparency, which impacts consistency and reliability
GHK-Cu longevity depends heavily on storage conditions, with room temperature exposure limited to 1-2 weeks for lyophilized material